Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07403539 · ClinicalTrials.gov registry record · NA
Speech Learning and Speech Production in Parkinson's Disease
A NA study of Parkinson's Disease, sponsored by State University of New York at Buffalo.
- Recruiting
- Registry status
- NA
- Development phase
- 50
- Enrollment target
- 1
- Study location
NCT07403539: Recruiting NA study of Parkinson's Disease, sponsored by State University of New York at Buffalo.
NCT07403539 is a NA study of Parkinson's Disease that is actively recruiting participants, run by State University of New York at Buffalo. The registered enrollment target is 50 participants, below the 635-participant average among 158 other Parkinson's Disease trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07403539, a NA study of Parkinson's Disease, is actively recruiting participants, sponsored by State University of New York at Buffalo.
- RECRUITING
- Registry status
- NA
- Development phase
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
Parkinson's disease, a common movement disorder that results from a breakdown in the brain, often leads to challenges with talking, but less is known about the relationship between difficulties with talking and difficulties with learning to understand speech. By linking these two abilities in individuals with Parkinson's disease using a precision medicine approach, this project seeks to build a basis for new therapies that help people with Parkinson's disease both understand better and speak more clearly.
Primary Outcome
The mean speech intensity (in dB SPL) will be assessed using a recording of spoken sentences and a spoken paragraph.
Conditions Studied
Interventions
- BEHAVIORAL Intensity learning
- BEHAVIORAL Intensity discrimination
- BEHAVIORAL Rate learning
- BEHAVIORAL Rate discrimination
Study Locations (1)
New York
- State University of New York at Buffalo - Buffalo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2026-01-27 |
| Est. Completion | 2027-12-31 |
| Phase | NA |
What NCT07403539 shows while recruiting
NCT07403539 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 635-participant average among 158 other Parkinson's Disease trials with a reported enrollment target (92% lower).
The record links to 1 condition, with Parkinson's Disease appearing as the primary indexed condition, and to 4 interventions - of which Intensity learning is the first listed.
NCT07403539 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT07403539 about?
NCT07403539 is a clinical study titled "Speech Learning and Speech Production in Parkinson's Disease". Parkinson's disease, a common movement disorder that results from a breakdown in the brain, often leads to challenges with talking, but less is known about the relationship between difficulties with talking and difficulties with learning to understand speech. By linking these two abilities in indivi...
What is the current status of trial NCT07403539?
This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2026-01-27. Estimated completion is 2027-12-31.
What conditions does trial NCT07403539 study?
This clinical trial studies the following conditions: Parkinson's Disease.
What interventions are being tested in trial NCT07403539?
The interventions under investigation include: Intensity learning (BEHAVIORAL), Intensity discrimination (BEHAVIORAL), Rate learning (BEHAVIORAL), Rate discrimination (BEHAVIORAL).
Who is sponsoring clinical trial NCT07403539?
This trial is sponsored by State University of New York at Buffalo, which has 243 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07403539 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Parkinson's Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07403539's enrollment target sits among peer trials
50 82nd of 158 higher than 73 of 158 other Parkinson's Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Parkinson's Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Novel DBS Stimulation Patterns for Treatment of Parkinson's Disease
RECRUITING · NA
-
Feasibility and Safety of a Portable Exoskeleton to Improve Mobility in Parkinson's Disease
RECRUITING · NA
-
Effects of Pallidal Deep Brain Stimulation Location on Motor Impairment in Parkinson's Disease
RECRUITING · NA
-
Remote Dynamic Cycling for the Customized Off-site Rehab in Parkinson's Disease
RECRUITING · NA
-
Deep Brain Stimulation Therapy in Movement Disorders
RECRUITING · NA
-
Combined STN and NBM Deep Brain Stimulation for Mild Cognitive Impairment in Parkinson's Disease
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI